137 related articles for article (PubMed ID: 10100133)
1. Menstrual cycling and breast cancer: an evolutionary perspective.
Strassmann BI
J Womens Health; 1999 Mar; 8(2):193-202. PubMed ID: 10100133
[TBL] [Abstract][Full Text] [Related]
2. Predictors of fecundability and conception waits among the Dogon of Mali.
Strassmann BI; Warner JH
Am J Phys Anthropol; 1998 Feb; 105(2):167-84. PubMed ID: 9511912
[TBL] [Abstract][Full Text] [Related]
3. The role of reproductive factors and use of oral contraceptives in the aetiology of breast cancer in women aged 50 to 74 years.
Magnusson CM; Persson IR; Baron JA; Ekbom A; Bergström R; Adami HO
Int J Cancer; 1999 Jan; 80(2):231-6. PubMed ID: 9935204
[TBL] [Abstract][Full Text] [Related]
4. Postponement of withdrawal bleeding in women using low-dose combined oral contraceptives.
Hamerlynck JV; Vollebregt JA; Doornebos CM; Muntendam P
Contraception; 1987 Mar; 35(3):199-205. PubMed ID: 2956054
[TBL] [Abstract][Full Text] [Related]
5. The prevention of breast cancer through reduced ovarian steroid exposure.
Spicer DV; Pike MC
Acta Oncol; 1992; 31(2):167-74. PubMed ID: 1622631
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology of menstruation and its relevance to women's health.
Harlow SD; Ephross SA
Epidemiol Rev; 1995; 17(2):265-86. PubMed ID: 8654511
[TBL] [Abstract][Full Text] [Related]
7. Ovarian function after the menarche and hormonal contraception.
Borsos A; Lampé L; Balogh A; Csoknyay J; Ditròi F; Székely P
Int J Gynaecol Obstet; 1988 Oct; 27(2):249-53. PubMed ID: 2903093
[TBL] [Abstract][Full Text] [Related]
8. The impact of contraceptive methods on the onset of symptomatic vulvovaginal candidiasis within the menstrual cycle.
Nelson AL
Am J Obstet Gynecol; 1997 Jun; 176(6):1376-80. PubMed ID: 9215201
[TBL] [Abstract][Full Text] [Related]
9. The clinical rationale for menses-free contraception.
Lin K; Barnhart K
J Womens Health (Larchmt); 2007 Oct; 16(8):1171-80. PubMed ID: 17937570
[TBL] [Abstract][Full Text] [Related]
10. Monitoring reproductive aging in a 5-year prospective study: aggregate and individual changes in steroid hormones and menstrual cycle lengths with age.
Ferrell RJ; O'Connor KA; Rodríguez G; Gorrindo T; Holman DJ; Brindle E; Miller RC; Schechter DE; Korshalla L; Simon JA; Mansfield PK; Wood JW; Weinstein M
Menopause; 2005; 12(5):567-77. PubMed ID: 16145311
[TBL] [Abstract][Full Text] [Related]
11. Monitoring of ovarian activity by daily measurement of urinary excretion rates of oestrone glucuronide and pregnanediol glucuronide using the Ovarian Monitor, Part III: variability of normal menstrual cycle profiles.
Blackwell LF; Vigil P; Cooke DG; d'Arcangues C; Brown JB
Hum Reprod; 2013 Dec; 28(12):3306-15. PubMed ID: 24170744
[TBL] [Abstract][Full Text] [Related]
12. The effect of RU486 administered during the proliferative and secretory phase of the cycle on the bleeding pattern, hormonal parameters and the endometrium.
Swahn ML; Johannisson E; Daniore V; de la Torre B; Bygdeman M
Hum Reprod; 1988 Oct; 3(7):915-21. PubMed ID: 2846630
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of ovulation by low-dose mifepristone (RU 486).
Ledger WL; Sweeting VM; Hillier H; Baird DT
Hum Reprod; 1992 Aug; 7(7):945-50. PubMed ID: 1331167
[TBL] [Abstract][Full Text] [Related]
14. Reproductive potential in the older woman.
Gindoff PR; Jewelewicz R
Fertil Steril; 1986 Dec; 46(6):989-1001. PubMed ID: 3536609
[TBL] [Abstract][Full Text] [Related]
15. Age at menarche, time to regular cycling, and breast cancer (North Carolina, United States).
Rockhill B; Moorman PG; Newman B
Cancer Causes Control; 1998 Aug; 9(4):447-53. PubMed ID: 9794178
[TBL] [Abstract][Full Text] [Related]
16. Communicating with patients about extended-cycle and continuous use of oral contraceptives.
Nelson AL
J Womens Health (Larchmt); 2007 May; 16(4):463-70. PubMed ID: 17521249
[TBL] [Abstract][Full Text] [Related]
17. Symptothermal and hormonal markers of potential fertility in climacteric women.
Flynn AM; James P; Collins WP; Royston P
Am J Obstet Gynecol; 1991 Dec; 165(6 Pt 2):1987-9. PubMed ID: 1755454
[TBL] [Abstract][Full Text] [Related]
18. Women's preferences for menstrual bleeding frequency: results of the Inconvenience Due to Women's Monthly Bleeding (ISY) survey.
Nappi RE; Fiala C; Chabbert-Buffet N; Häusler G; Jamin C; Lete I; Lukasiewic M; Pintiaux A; Lobo P
Eur J Contracept Reprod Health Care; 2016 Jun; 21(3):242-50. PubMed ID: 27010535
[TBL] [Abstract][Full Text] [Related]
19. Breast cancer and hormonal contraceptives: further results. Collaborative Group on Hormonal Factors in Breast Cancer.
Contraception; 1996 Sep; 54(3 Suppl):1S-106S. PubMed ID: 8899264
[TBL] [Abstract][Full Text] [Related]
20. Iron status in 268 Danish women aged 18-30 years: influence of menstruation, contraceptive method, and iron supplementation.
Milman N; Clausen J; Byg KE
Ann Hematol; 1998; 77(1-2):13-9. PubMed ID: 9760147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]